The new facility will expand Brookwood’s capacity for R&D activities and clinical manufacturing in support of customer projects. Additionally, the building will be SurModics’s corporate center for commercial
ReNeuron’s ReN003 human retinal progenitor cells were tested in a rodent model of damaged retina. Between 14 and 28 days after transplantation into the sub-retinal space, the cells
The addendum marks the second extension of the agreement signed in 2002, and gives China Medical System Holdings (CMS) the exclusive right to sell Deanxit in China from
As a result, full title to the urokinase assets, including the remaining inventory of finished product, all regulatory and clinical documentation, validated cell lines, and intellectual property rights,
Wyeth’s action is based on its understanding of the Committee for Medicinal Products for Human Use (CHMP) assessment that the Tygacil community-acquired pneumonia (CAP) pivotal clinical trials did
In the re-read of images obtained from previous phase III studies, Epix met all pre-specified endpoints prospectively agreed to with the FDA. Epix plans to resubmit a new
This multi-million dollar research contract will focus on risk assessment and reduction in cardiovascular disease and other disease areas of interest to the customer. Entelos will receive technology
Under the terms of the contract, Acambis will establish a US-based manufacturing capability for ACAM2000, deliver against Centers for Disease Control and Prevention (CDC) orders for a minimum
Paion will be required to make a milestone payment in the event flovagatran receives regulatory approval or is licensed or sold in a major market but will not
Vyvanse, introduced in July 2007 for the treatment of attention deficit hyperactivity disorder (ADHD) in children aged 6 to 12 years, is now said to be the first
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.